Categories

GLP-1s’ direct and indirect impacts on health care and consumer goods – Jane speaks with Bloomberg BNN

Today, I spoke live with Paul Bagnell, news anchor with Bloomberg BNN, on the topic of the GLP-1 agonists and their impact on health care, industries beyond health and medicine, and consumers. In this post, I’ll share with you some of the plotline for our discussion.               Gallup polled U.S. adults in March to gauge their experience with injectable weight loss drugs, the results published earlier this week. The first chart tells us that 6% of people have used these drugs, and 3% were doing so in March. Consumers using the meds were more

 

Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update

In the past year, the growth of prescription drug utilization and spending has much to do with the use of GLP-1 agonists to treat diabetes and obesity, along with immunology therapy, and lipid meds, along with specialty medicines now accounting for over half of spending — up from 49% in 2018. This update comes from The Use of Medicines in the U.S. 2024 from the IQVIA Institute for Human Data Science. The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028.

 

Telehealth Legislation Passes Ways & Means, As GLP-1s Are Fast-Meshing with Telemedicine in the Marketplace

Yesterday, the U.S. House Committee on Ways and Means passed six pieces of legislation that would bolster telehealth in the U.S. for the next two years, assuring several aspects of access for health citizens across the country. “One of our top priorities on this Committee is helping every American access health care in the community where they live, work, and raise a family,” Committee Chairman Jason Smith (R-Mo.) explained in his introductory statement. Being from Missouri, Chairman Smith is especially keen on the role virtual care and telehealth can play to expand access to the under-served in the U.S. “In rural

 

The Cost of Medical Care, Long-Term Care, and Prescription Drugs Top Older Americans’ Health-Related Concerns – With Social Security and Medicare Top of Mind

Among Americans 50 years of age and over, the top health-related concerns are Cost, Cost, and Cost — for medical services, for long-term and home care, and for prescription medications. Quality of care ranks lower as a concern versus the financial aspects of health care in America among people 50 years of age and older, as we learn what’s On Their Minds: Older Adults’ Top Health-Related Concerns from the University of Michigan Institute for Healthcare Policy and Innovation. AARP sponsors this study, which is published nearly every month of the year on the Michigan Medicine portal.           

 

Healthcare 2030: Are We Consumers, CEOs, Health Citizens, or Castaways? 4 Scenarios On the Future of Health Care and Who We Are – Part 1

In the past few years, what event or innovation has had the metaphorical impact of hitting you upside the head and disrupted your best-laid plans in health care? A few such forces for me have been the COVID-19 pandemic, the emergence of Chat-GPT, and Russia’s invasion of Ukraine. That’s just three, and to be sure, there are several others that have compelled me to shift my mind-set about what I thought I knew-I-knew for my work with organizations spanning the health care ecosystem. I’m a long-time practitioner of scenario planning, thanks to the early education at the side of Ian

 

Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In

Since the introduction of GLP-1 drugs on the market, their use has split into two categories: for obesity and “recreationally,” according to the Chief Economist with UBS (formerly known as Union Bank of Switzerland). Paul Donovan, said economist, discusses The economics of getting thin in his regularly published comment blog.                   “These different uses have different economic consequences,” Donovan explains: Obese patients who use GLP-1s should become more productive employees, Donovan expects — less subject to prejudice, and less likely to be absent from work. While so-called recreational GLP-1 consumers may experience these

 

The Self-Prescribing Consumer: DIY Comes to Prescriptions via GLP-1s, the OPill, and Dexcom’s CGM

Three major milestones marked March 2024 which compel us to note the growing role of patients-as-consumers — especially for self-prescribing medicines and medical devices. This wave of self-prescribed healthcare is characterized by three innovations: the Opill, GLP-1 receptor agonists, and Dexcom’s Continuous Glucose Monitoring (CGM) system that’s now available without a prescription. Together, these products reflect a shift in health care empowerment toward patients as consumers with greater autonomy over their health care when the products and services are accessible, affordable, and designed with the end-user central to the value proposition and care flows. Let’s take a look at each

 

Peering Into the Hidden Lives of Patients: a Manifesto from Paytient and Nonfiction

Having health insurance in America is no guarantee of actually receiving health care. It’s a case of having health insurance as “necessary but not sufficient,” as the cost of deductibles, out-of-pocket coinsurance sharing, and delaying care paint the picture of The Hidden Lives of Workplace-Insured Americans.                 That’s the title of a new report that captures the results of a survey conducted in January 2024 among 1,516 employed Americans who received employer-sponsored health insurance. The study was commissioned by Paytient, a health care financial services company, engaging the research firm Nonfiction to conduct the study

 

While Virtual Care is “Table Stakes” in Health Care, Consumers Are Growing More Protective About Data-Sharing

Three in four people in the U.S. have used virtual care, now, “Table-stakes…here to stay for patients and providers. However, that ubiquity comes with its own set of market pressures…shifting from pandemic-responsiveness to market- and consumer- responsiveness,” according to The new era of consumer engagement, Rock Health’s ninth annual Consumer Adoption Survey published 18 March.            Convenience and waiting time are the top two reasons for choosing virtual over in-person care, Rock Health found. While virtual care is ubiquitous across the U.S. health care delivery landscape, patients-as-health care consumers are becoming more savvy and discriminating based

 

The Economic Contours of the Change Healthcare Cyber Attack: Taking Stock So Far

On February 22, 2024, I went to a CVS Pharmacy-Inside-Target in my community to fill a prescription for benzonatate 200 mg capsules. I had caught a bad case of the flu the week before, and subsequently suffered a very long tail of a cough. That’s TMI for me to write about in the Health Populi blog, but this story has a current-events twist: the pharmacist could not electronically link with my insurance company to transact my payment. He tried a few work-flows, and ended up using a discount card which in the moment worked for us, and I paid the

 

The Women’s Health Gap Is Especially Wide During Her Working Years – Learning from McKinsey, the World Economic Forum, and AARP in Women’s History Month

There’s a gender-health gap that hits women particularly hard when she is of working age — negatively impacting her own physical and financial health, along with that of the community and nation in which she lives.               March being Women’s History Month, we’ve got a treasure-trove of reports to review — including several focusing on health. I’ll dive into two for this post, to focus in on the women’s health gap that’s especially wide during her working years. The reports cover research from the McKinsey Health Institute collaborating with the World Economic Forum on

 

HeartMates, Bringing Community and Heart Health Love from Damar Hamlin – Abbott at #CES2024

The heart is a major health-category at CES 2024, from wristband wearable tech to remote health monitoring devices enabling cardiovascular hospital-to-home care. Abbott, one of the first life science companies to exhibit at CES back in 2022, announced the HeartMates program here at #CES2024 today as part of a panel titled Ahead of the Game: Revolutionizing Athlete Safety with Emerging Health Tech. I have both professional and personal interests in athlete safety, having two nephews who have been involved in acute sports injury and brain health. The panel discussion featured the latest research findings on injury prevention and recovery, with

 

The Health Consumer in 2024 – The Health Populi TrendCast

At the end of each year since I launched the Health Populi blog, I have put my best forecasting hat on to focus on the next year in health and health care. For this round, I’m firmly focused on the key noun in health care, which is the patient – as consumer, as Chief Health Officer of the family, as caregiver, as health citizen. As my brain does when mashing up dozens of data points for a “trendcast” such as this, I’ll start with big picture/macro on the economy to the microeconomics of health care in the family and household,

 

Nurses Earn Highest Grade for Care Far Above All Other Health Care Workers — Including Doctors — In Latest Gallup Poll

Nurses rank highest among various factors in the U.S. health system in the latest Gallup poll — earning a grade of “excellent” or “good” by American adults surveyed in November 2023.               Further substantiation for nurses’ topping this poll of excellent care is that Gallup found historic low confidence in the U.S. health system among Americans  earlier this year in a July study. Note that 8 in 10 consumers rate nurses excellent/good compared with  7 in 10 people ranking physicians this way, 6 in 10 for hospitals, 5 in 10 for telemedicine/virtual visits, and

 

What Walmart’s Look at Ozempic Users Tells Us About Health/Care Consumers

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” the CEO of Walmart US is quoted in Bloomberg. “Just less units, slightly less calories.”                   With patients’ use  GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro fast-rising in the pharmacy market, so are the concerns of companies that stock the-middle-of-the-grocery-store aisles for processed foods like sweet and salty snacks. As the prospects for the drug companies who manufacture prescription drugs made for patients managing diabetes and obesity are on the

 

Food-As-Medicine Grows Its Cred Across the Health/Care and Retail Ecosystem

In the nation’s search for spending smarter on health care, the U.S. could save at least $13 billion a year through deploying medically-tailored meals for people enrolled in Medicare, Medicaid, and private insurance programs, according to the True Cost of Food, research published by the Tufts School of Nutrition Science and Policy collaborating with The Rockefeller Foundation.       It’s been one year since the White House convened the Conference on Hunger, Nutrition, and Health, kicking off the Biden Administration’s national strategy to improve health citizens’ access to healthy food as a matter of public health and economic security.

 

Slip Slidin’ Away: the Reputations of Pharma and Healthcare in the U.S. Decline in the Latest Gallup Poll

Oh, how quickly people forget…and slow to forgive. U.S. consumers’ positive views for healthcare, pharma and retail have significantly fallen in just one year, the latest annual Gallup poll of industry rankings in America found as of August 2023. This stat for the pharma industry was the lowest Gallup ever recorded for the sector since 2001.                     I can’t help hearing Paul Simon’s lyrics to Slip Slidin’ Away….”you know the nearer your destination, the more you’re slip slidin’ away” when it comes to health citizens’ perceptions of pharma and the healthcare

 

Personalizing Health Means Personalizing Health Insurance for Patient-Members – Learning from HealthEdge

As patients assume more financial skin in their personal healthcare, they take on the role of demanding consumer, or “impatient patients.” HealthEdge’s latest research into health consumers’ perspectives finds peoples’ satisfaction with their health insurance plans lacking, with members seeking easier access their personal health information, high levels of service, and rewards for healthy behaviors.           Health plans would also boost consumers’ satisfaction by channeling patients’ access to the kinds of medical providers that align with consumers’ preferences and personal values, and by personalizing information to steer people toward lower-cost care.          

 

Hims and Hers and Hearts – Cardiology Blurs Into DTC Retail Health

Statin therapy has been used for decades to lower cholesterol with the goal of reducing mortality and preventing cardiovascular problems such as heart attacks and strokes. Hims & Hers announced a new service offering for health consumers and clinicians concerned about heart health called Heart Health by Hims.               This is Hims & Hers’ first foray into cardiovascular health, working in collaboration with the American College of Cardiology (ACC). ACC clinical guidelines will inform the Hims’ provider platform for the program. “Prevention is the ideal mechanism to decrease cardiovascular events and ensure optimal heart

 

Pharmacy Plays a Growing Role in Consumers’ Health@Retail – J.D. Power’s 2023 Rankings

“Brick-and-mortar pharmacies forge meaningful connections with customers” through conversations between pharmacists and patients, “on a first-name basis.” This quote comes from Christopher Lis, managing director of global healthcare intelligence at J.D. Power who released the company’s annual 2023 U.S. Pharmacy Study today, the 15th year the research has been conducted.                           Each year, J.D. Power gauges U.S. consumers’ views on retail pharmacies in four channels: brick and mortar chain drug stores, brick and mortar mass merchandisers, brick and mortar supermarkets, and mail order. Across all four channels, the

 

There’s a New “O” in Medicine-Town – Welcome OPill to the Front of the Counter

You may not be able to get that ear-worm jingle that goes “O O O Ozempic” out of your musical mind, but I’m happy to tell you there’s a new “O” in town: the Opill. Welcome to the first OTC contraceptive for sale in the USA.                     I wrote about Perrigo’s Opill here in Health Populi in May 2023 as a “signpost on the road to retail health.” It’s official: “The U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages.

 

Happy Amazon Prime Days, When You Can Get 25% Off a Year’s One Medical Membership

Now in Aisle E(commerce) – get your one-year membership to One Medical for $149. Today and tomorrow are Amazon Prime Days, 2023 style, when you can fetch bargains on lots of electronics (esp. deeply-discounted Amazon-branded devices), sporting goods, kitchen gear, pet supplies, and even groceries (saving with Amazon Fresh getting $20 off $100+ orders on Prime Day).                       And among a vast menu of health, medical, and well-being offerings from collagen to gym equipment and blood pressure monitors is that One Medical membership good for a year of services. “On-demand

 

Patients-As-Health Care Payers Define What a Digital Front Door Looks Like

In health care, one of the “gifts” inspired by the coronavirus pandemic was the industry’s fast-pivot and adoption of digital health tools — especially telehealth and more generally the so-called “digital front doors” enabling patients to access medical services and personal work-flows for their care. Two years later, Experian provides a look into The State of Patient Access: 2023.                     You may know the name Experian as one of the largest credit rating agencies for consumer finance in the U.S. You may not know that the company has a significant footprint

 

Consumers and Cancer: 3 Patient-Focused Charts From IQVIA on the State of the Oncology in 2023 – and Introducing CancerX

It’s time for the annual ASCO conference, currently convening the American Society for Clinical Oncology in Chicago. Starting 2nd June, there have been dozens of positive announcements updating research and therapies bringing hope to the 2 million new patients who will be diagnosed with cancer in the U.S. in 2023, and millions of more people worldwide. Just in time for #ASCO2023, the IQVIA Institute published their annual report on Global Oncology Trends 2023 – Outlook to 2027, an update featuring pipelines, therapy approvals, research updates, costs of oncology products, and patients.                  

 

Searching for Health/Care Touchpoints in the 2023 Axios Harris Poll 100

Patagonia, Costco, John Deere, and Trader Joe’s are loved; Twitter, Fox Corp., FTX and The Trump Organization? Not so much. Welcome to 2023 Axios Harris Poll 100 list of companies U.S. consumers rate from excellent in terms of reputation to very poor and, one in particular, “critical.” Exploring the list, we can find insights into consumers’ preferred touchpoints for health, health care, and well-being curated in their daily lives. In this, today’s, Health Populi blog, I consider The 2023 Axios Harris Poll 100 reputation rankings in light of what we learned from the Morning Consult Most Trusted Brands 2023 study

 

Getting Health Care at a Retail Pharmacy vs a Retail Store: Consumers May Be Favoring the Pharmacist Versus the Retailer

Not all “retail health” sites are created equal, U.S. consumers seem to be saying in a new study from Wolters Kluwer Health, the company’s second Pharmacy Next: Consumer Care and Cost Trends survey. Specifically, consumers have begun to differentiate between health care delivered at a retail pharmacy versus care offered at a retail store — such as Target or Walmart (both named as sites that offer “health clinics in department stores” in the study press release). While 58% of Americans were likely to visit a local pharmacy as a “first step” when faced with a non-emergency medical situation and 79%

 

Three More Signposts on the Road to Retail Health – Weight Loss Drugs, OTC Birth Control and Fashion-Meets-the-Flu

We continue to track to evolving, expanding landscape of retail health — which we see as the expanding ecosystem of health/care accessible to people-as-health consumers. This week, three intriguing examples are resonating with us: The ever-evolving weight-loss industry FDA favors OTC use for Perrigo’s Opill daily oral contraceptive birth control pill The convergence of fashion and health — specifically, how an over-the-counter medicine converges with clothing that helps us feel better.                   Let’s start with weight-loss, as several aspects of health/care come together in the consumer’s retail health sandbox. Dr. Eric Topol

 

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. is always a detailed, deep, and insightful dive into the state of prescription drugs. It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. In my read of this year’s review, I see a flashing light for U.S. health care: “Wake up, public health!” I’ve pulled out a few of the data points that speak to me about population health, prevention and early

 

Thinking Pharma on a Friday: Europe’s Big Reforms for a Health Union & the U.S. 50-State Fragments

The COVID-19 pandemic re-shaped European Union leaders to reimagine healthcare, public health, and health citizenship in the EU. Welcome to #HealthUnion, the hashtag that the European Commission has adopted with the vision of assuring access to medicines for all people living in the 27-nation EU area — regardless of socioeconomic status.             On 26th April 2023, the EC unveiled the most significant reforms for the region’s pharmaceutical industry in twenty years. It’s really a package or “toolkit” in the words of EC Health and Food Safety Commissioner Stella Kyriakides for addressing several strategic health pillars

 

Food Is Medicine, Especially When You Are Hungry – The American Heart Association‘s FIM Initiative

Food is a basic need, fundamental to our lives and well-being. And for millions of people around the world, and innumerable health citizens in the U.S., food security is part of daily life in 2023. Furthermore, as the U.S. Congress faces voting on the debt ceiling, the issue of SNAP benefits for nutritional assistance (aka “food stamps”) has been identified as a negotiating line-item by certain Federal budget-cut minded folks. That’s why the Food Is Medicine Initiative, launched collaboratively between the American Heart Association and The Rockefeller Foundation, is so timely and welcome.         “The vision for

 

More Consumers Expect Health/Care Companies to Be Purpose-Ful Versus All Other Industries

If your organization serves health consumers, patients, and caregivers, and you’re asking them to spend money on your services or products, then you’ll do well to be clear on your values and sense of purpose. In the latest Ipsos look into the future of “Purpose,” we find that consumers look most to health and pharmacy companies for shared values, compared with other industries people patronize such as food and grocery, technology and banks.                   To understand where Ipsos is coming from on this aspect of ESG, we’ll start with their territory map

 

Growing DTC for Health Beyond the Rx – the New Health/Care at Home

As our homes and health care services continue to converge, we can see signposts of direct-to-consumer strategies from the pillbox (where DTC is a mature thing) to clinical care in peoples’ hands (and on their preferred technology platforms). Some examples this week make this point, which taken together demonstrate the portfolio of ways more people – as health consumers and caregivers – can engage in their health, well-being, and clinical care.             Start with Best Buy’s announcement that they will collaborate with the health system Atrium Health to bolster hospital-to-home effectiveness and activation between hospitals

 

Enabling better health care, everywhere – my conversation with Microsoft

I am grateful to have been given the opportunity to brainstorm omnichannel health care for people to enable better health care for all, anywhere and everywhere, with Team Microsoft. Key opinion leader Molly McCarthy and I covered a lot of ground in this webcast conversation as part of Microsoft’s series of three “Expert  perspectives on trends driving change in healthcare.”             Molly and I covered a lot of ground here, starting with the key forces shaping and accelerating virtual care across the continuum. While these were in place before the COVID-19 pandemic, the public health

 

The Reputation of Pharma Among U.S. Consumers Is Tied More to Pricing Than to Innovation

In the U.S., price and the cost of medicines is tied to how people feel about the pharma industry, evidenced in the Global Pharma Study 2023 from Caliber. Caliber, a reputation and corporate strategy consultancy, fielded survey research among over 17,000 health consumers including U.S. adults between 18 and 75 years of age as well as health citizens living in Brazil, China, France, Germany, Japan, and the UK.                 Caliber assessed the reputation of 16 industries, globally, finding that pharma ranked 10th among the 16, just below automotive and just above chemicals (and well

 

Your Grocery Store as Health/Care Destination: Welcome Kroger to the Clinical Trials Community

Our grocery stores were essential touchpoints for us during the COVID-19 lockdown era and thereafter, addressing our basic needs for food and medicines and even social health from early 2020 and since.             Grocery stores have been morphing into health/care destinations for the past decade, in the best cases bolstering nutrition, supporting medication adherence and patient outcomes, and helping us curate healthy grocery carts with nutritionists as part of the store pharmacy team. Now Kroger continues to expand its health/care footprint and capabilities, becoming a clinical trials channel as announced in its January 24th press

 

When Household Economics Blur with Health, Technology and Trust – Health Populi’s 2023 TrendCast

By Jane Sarasohn-Kahn on 22 December 2022 in Anxiety, Behavioral health, Big data and health, Big Tech, Broadband, Business and health, Cardiovascular health, Chronic care, Chronic disease, Connected health, Consumer electronics, Consumer experience, Consumer-directed health, Coronavirus, COVID-19, Cybersecurity, Data analytics and health, Demographics and health, Depression, Design and health, Determinants of health, Diet and health, Digital health, Employee benefits, Employers, Financial health, Financial wellness, Fitness, Food and health, Grocery stores, Health apps, Health at home, Health benefits, Health care industry, Health citizenship, Health Consumers, Health costs, Health disparities, Health Economics, Health ecosystem, Health engagement, Health equity, Health insurance, Health Plans, Health policy, Health politics, Health privacy, Healthcare DIY, Heart disease, Heart health, HIPAA, Home care, Home economics, Home health, Hospitals, Infectious disease, Love and health, Medication adherence, Meditation, Mental health, Mindfulness, Moms and health, Money and health, Out of pocket costs, Patient experience, Personal health finance, Pharmaceutical, Pharmacy, Physicians, Popular culture and health, Prescription drugs, Prevention and wellness, Primary care, Public health, Race and health, Remote health monitoring, Retail health, Risk management, SDoH, Self-care, Shopping and health, Social determinants of health, Specialty drugs, Stress, Telehealth, Telemedicine, Transparency, Trust, User experience UX, Vaccines, Value based health, Virtual health, Vitamins, Wearable tech, Wellbeing, Workplace benefits

People are sick of being sick, the New York Times tells us. “Which virus is it?” the title of the article updating the winter 2022-23 sick-season asked. Entering 2023, U.S. health citizens face physical, financial, and mental health challenges of a syndemic, inflation, and stress – all of which will shape peoples’ demand side for health care and digital technology, and a supply side of providers challenged by tech-enabled organizations with design and data chops. Start with pandemic ennui The universal state of well-being among us mere humans is pandemic ennui: call it languishing (as opposed to flourishing), burnout, or

 

Dollar General & CHPA Collaborate to Bolster Health Consumers’ Literacy and Access for OTC Pain Meds and Self-Care

Health is “made” where we live, work, play, pray, learn….and shop. I spend a lot of time these days in the growing health/care ecosystem where retail health is broadening to address social determinants and drivers of health – namely food, transportation, broadband access, education, environment, and financial wellness – all opportunities for self-care and health engagement. For many years, I have followed the activities of CHPA, the Consumer Healthcare Products Association, and have participated in some of their conferences. Their recent announcement of a collaboration with Dollar General speaks to the growing role of self-care for all people.    

 

Consumers Are Feeling Their Healthcare Cost of Living – Research from Qualtrics

Rising costs are the #1 reason U.S. health consumers are avoiding or delaying health care, replacing concerns about COVID-19, based on survey research from Qualtrics.         The company’s Healthcare Cost of Living survey research learned that 48% of U.S. adults chose to defer health care in 2022, split by 31% of consumers skipping care due to cost concerns, and, 17% of people delaying care who had concerns about the coronavirus. Note the types of care delayed or skipped: Over 27% of people delayed care related to nutrition 26% delayed routine or preventive care, such as screenings or

 

Consumers’ Trust In Pharmacists As Providers Grows Along with Omnichannel Health Care

What is a “pharmacy” these days? You might have recently walked into a brick-and-mortar retail pharmacy. Or, you might have refilled a prescription to help you manage a chronic condition, online. Or, perhaps, you asked the pharmacist staffing your favorite grocery store Rx counter to give you the latest vaccine to keep COVID-19 variants at-bay. The pharmacy is all these things, and increasingly digital-first, we learn in The Rx Report: A new day in retail pharmacy, a consumer survey from CVS Health.         CVS Health, one of the two largest pharmacies operating in the U.S. in 2021

 

How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

What happens to a health care ecosystem when the volume of patients and revenues they generate decline? Add to that scenario a growing consensus for a likely recession in 2023. How would that further impact the micro-economy of health care?                   A report from Trilliant on the 2022 Trends Shaping the Health Economy helps to inform our response to that question. Start with Sanjula Jain’s bottom-line: that every health care stakeholder will be impacted by reduced yield. That’s the fewer patients, less revenue prediction, based on Trilliant’s 13 trends re-shaping the U.S. health

 

Health in the 2022 U.S. Midterm Elections – Women, Prescription Drugs, and Who Shows Up to Vote

On Tuesday November 8, 2022, health and medical issues will be on many U.S. voters’ minds as they enter voting booths to select representatives for the House and the Senate, along with some states’ ballots addressing specific healthcare issues. Health policy experts from Manatt, Phelps & Phillips, AARP, and the United States of Care recently shared perspectives on the health care issues on voters’ and policy makers’ minds for the 2022 midterm elections. This post synthesizes their analyses as we lead up to what will be a pivotal election for Americans’ public health, individual well-being, and access to care.  

 

The Patient as Prescription Drug Payer – The GoodRx Playbook

Patients have more financial skin-in-their-healthcare-games facing high-deductibles and direct out-of-pocket costs for medical bills…including prescription drugs. I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer, with implications and calls-to-action for pharma and life science companies. You can download the paper at this link.               The report is intended to be a playbook for understanding patients’ growing role as consumers and health care payers, providing insights into peoples’ home economic mindsets and how these impact a patient’s adherence to medication based on cost and perceived value. With inflation facing household

 

Telehealth-As-Healthcare Is a Mainstream Expectation Among Consumers, J.D. Power Finds

Telehealth has increased access to mental health services, I’ve highlighted this Mental Illness Awareness Week here in Health Populi. But telehealth has also emerged as a preferred channel for routine health care services, we learn from J.D. Power’s 2022 Telehealth Satisfaction Study.           Among people who had used virtual care in the past year, telehealth-as-healthcare is now part of mainstream Americans’ expectations as a normal part of their medical care. That’s because 9 in 10 users of telehealth in the U.S. would use virtual care to receive medical services in the future, J.D. Power found in

 

Remember the Social Determinants of Health When Prescribing Drugs

Thinking about the social determinants of prescription drugs, how people take medicines in real life in my latest post in Medecision’s Liberate Health blog.           I had one of those special lightbulb moments when listening to Mauricio Gonzalez-Arias, M.D. of NYC Health + Hospitals and Suvida Healthcare discussing medication adherence and what prevents us from taking our meds as prescribed. His discussion on social determinants’ role in shaping our relationship with prescriptions was powerful, and the jumping off point for this essay.           Medication adherence is a challenge that fiscally costs the

 

Gallup Reveals Americans’ Views on Industry Are the Lowest Since 2008 – Implications for Healthcare and Pharma

Americans’ positive views of 25 industries in the U.S. have declined in the past year. In their latest look into consumers’ views on business in America, Gallup found that peoples’ ratings on business fell to their lowest ratings overall since 2008.           Peoples’ highest ratings of industry in American occurred in 2017 when nearly 50% of people gave business a very or somewhat positive grade. The year-on-year decline from 2021 find oil and gas at the lowest level of positivity, advertising/PR, legal, the Federal government, and pharma at the bottom of the ratings.      

 

Partnering Up in the Health Care Ecosystem to Drive Transformation – for Organizations and Health Consumers Alike

“Partnerships, including JVs and alliances with other healthcare organizations and with new entrants, are just one way to access new capabilities, unlock speed to market, and achieve capital, scale, and operational efficiencies” in health care transformations. “In an environment with continued competition for attractive assets and significant capital in play from institutional investors, these partnerships may also be the most accessible way for organizations to capture value in expanding healthcare services and technology value pools,” we learn in Overcoming the cost of healthcare transformation through partnerships from a team of health care folks with McKinsey & Company.      

 

Americans Rationing Healthcare in the Inflationary Era; Out-of-Pocket Expenses Are the Concern

Nearly 100 million people in the U.S. cut back on healthcare due to costs in the first half of 2022, according to the latest poll on health care costs form Gallup and West Health, gauging Americans’ financial health in June 2022. That’s the month when inflation in the U.S. reached 9.1%, a 40-year high.             Among Americans’ cuts to household spending was the most common medical self-rationing behavior, delaying or avoiding  care or purchasing prescription drugs, the survey found. Nearly 4 in 5 people in the U.S. had delayed care or prescription meds between January

 

Patient Support Isn’t Just About the Price of Therapy: It’s About Safety, Really Rich Data and Trust

When I talk about patient support programs (PSPs), I’m most often focused on supporting peoples’ access to medicines due to costs, bolstering health literacy, and addressing health citizens’ risks of drivers of health that can be obstacles to optimal health outcomes (those challenging social determinants of health). A new report from Deloitte on Intelligent post-launch patient support speaks to another crucial definition of patient support: post-market surveillance and patient safety.                 The paper’s central thesis is that improving patient support is a critical step in the biopharma value chain, illustrated in the first diagram

 

The Old Gays Working with Walgreens on TikTok: Breaking Down Stereotypes and Having Fun with Health

How much do I love this media campaign from Walgreens, collaborating with the foursome The Old Gays who have a growing multi-million person fan base on TikTok? How much? A whole lot! Kudos to Walgreens for creating engaging, informative, and fun! content to learn about how people can benefit from using the company’s app ….for, Ordering prescriptions (90-day supply) Receiving delivery same-day 24/7 pharmacy chat on pricing, prescription drug information, and medications. The plotline kicks off with 3 of the 4 quartet (Jessay Martin, Robert Reeves and Mick Peterson) looking for their friend Bill Lyons, who is missing from their

 

The Unbearable Heaviness of Inflation: Will Consumers’ Financial Stress Erode Their Health?

“Inflation is the big story,” the economics team at Morning Consult told us yesterday in a call on “How to Think Like An Economist.” While I already thought I did that, Team @MorningConsult updated us on the current state of consumers and what’s weighing most heavily on their minds…inflation being #1. An hour after the Morning Consult session, I brainstormed the topic of consumers-as-payers of medical bills and prescription drugs with GoodRx strategy leaders. In my data wonkiness, inflation certainly played a starring role in setting the stage for Mind, Body and Wallet — the title of one of the sources

 

Only in America: Medical Debt Is Most Peoples’ Problem, KHN and NPR Report

When high-deductible health plans became part of health insurance design in America, they were lauded as giving patients “more skin in the game” of health care payments. The theory behind consumer-directed care was that patients-as-consumers would shop around for care, morph into rational consumers of medical services just as they would do purchasing autos or washing machines, and shift the cost-curve of American health care ever downward. That skin-in-the-game has been a risk factor for .some patients to postpone care as well as take on medical debt — the strongest predictor of which is dealing with multiple chronic conditions. “The

 

The Evolution of a Patient Ambassador – Learning from Stacy Hurt

“I am a health care executive who happens to be a patient, caregiver, and advocate,” Stacy Hurt explained to me in a Zoom chat we shared on 31 May. I asked her to meet with me to discuss her professional news update: being appointed Parexel’s first Patient Ambassador.                       My Zoom invitation to Stacy was a very convenient excuse for me to catch up with a friend in the field: we have known each other since Stacy started to grow her health-social media presence on Twitter. And that involvement in

 

What If Costco Designed the Prescription Drugs Sales Model?

The good news about prescription drugs, in the context of medical spending in the U.S., is that 9 in 10 medicines prescribed are generics. They comprise only 3% of all U.S. healthcare spending.           But there’s bad news about prescription drugs in the context of medical spending in America. U.S. Consumers Overpay for Generic Drugs, a new paper from the Leonard Schaeffer Center for Health Policy & Economics asserts, with recommendations to address the intermediaries who benefit from the way Americans currently pay for medicines. Generics are “an American success story,” the authors call out, bringing

 

A New Chevy Equinox SUV, a Year in Grad School, or Health Care for Four – The 2022 Milliman Medical Index

A new Chevy Equinox SUV, a year in an MS program in kinesiology at Pacific Lutheran U., or health care for a family of four. At $30,260, you could pick one of these three options.             Welcome to this year’s 2022 Milliman Medical Index, which annually calculates the health care costs for a median family of 4 in the U.S. I perennially select two alternative purchases for you to consider aligning with the MMI medical index. I have often picked a new car at list price and a year’s tuition at a U.S. institution of

 

How Trust and Geopolitics Will Impact Health and Business – Edelman 2022 Trust Barometer at the World Economic Forum in Davos

When we think about the state of Trust in in mid-2022, there is some good news: Trust is rising (at least in democratic countries, while falling in autocratic ones). The bad news: the gap in Trust has dramatically widened between higher-income people compared with those earning lower-incomes, globally.             And that gap is “tinder” that can be quickly sparked into a socio-political fire in countries around the world, Richard Edelman cautioned today when introducing the latest look at the 2022 Edelman Trust Barometer, focusing on geopolitics and business. We have never seen numbers like this

 

Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity

The COVID-19 pandemic has impacted patients who were already deeply engaged with their own health care before the coronavirus emerged. Compared with a year ago, more patients and their advocates are seeking quality therapies, innovation, engagement, and integrity from pharmaceutical companies, based on research published today from PatientView. PatientView, based in the UK, has collaborated with over 40,000 patient advocacy organizations globally marking over 10 years doing this research. The eleventh annual report on the Corporate Reputation of Pharma was conducted among 2,150 patient groups between November 2021 and February 2022, covering health citizens in Europe (with 1,229 organizations), North

 

What Person-Centered Interoperability Looks Like: Seqster

He had me at the statement, “I believe health data is medicine.” Those were the words of Ardy Arianpour, CEO and Co-Founder of Seqster, when sharing with me how his company was founded. We met up last week at the DIA Europe 2022 meeting (Drug Information Association) in the cool SQUARE Conference Center in Brussels, Belgium (my current home base for work and life). It was a rare opportunity to sit still with this on-the-go guy with whom an hour spent is the equivalent of three hours with most other folks. Ardy and the team call Seqster “the operating system

 

Can a Food-As-Medicine App Extend Chronic Health Management at the Grocery Store?

Foogal, a recipe app designed to support patients’ healthy cooking and eating, launched on 24th March. In its initial version, Foogal addresses several specific diet paradigms: for patients demanding a wellness protocol, an autoimmune protocol, or wanting to address insulin resistance. Foogal got my attention via a tweet @FoogalApp on 25th March. The snippet featured a photo of a delectable Salad Lyonnaise, one of my favorite things to eat, which adds a soft-cooked egg and bacon lardons to the greens for an easy light (and delicious!) meal. Foogal was developed by Todd Knobel, who has worked in law, in plastics,

 

The Financial Toxicity of Health Care Costs: From Cancer to FICO Scores

The financial toxicity of health care costs in the U.S. takes center stage in Health Populi this week as several events converge to highlight medical debt as a unique feature in American health care. “Medical debt is the most common collection tradeline reported on consumer credit records,” the Consumer Financial Protection Bureau called out in a report published March 1, 2022. CFPB published the report marking two years into the pandemic, discussing concerns about medical debt collections and reporting that grew during the COVID-19 crisis. Let’s connect the dots on: A joint announcement this week from three major credit agencies,

 

Human-Powered Health: How Abbott Is Unlocking the “Possibility of You” at CES 2022

Yesterday, we heard all about autonomous cars and sustainable mobility from Mary Barra, CEO of General Motors. Autos, TVs, and telecomms are the usual fare of the big stage speeches at the annual big show of consumer electronics. Gary Shapiro, President and CEO of CTA, introduced today’s CES keynote speaker, Robert Ford, as the “first-ever keynote speaker from health care” at CES, calling out the fact that Abbott’s Freestyle Libre System garnered one of CES 2022’s Innovation Awards. Ford is the Chairman and CEO of Abbott, one of the largest global life sciences companies. Ford let us know up-front that

 

Health Care Planning for 2022 – Start with a Pandemic, Then Pivot to Health and Happiness

One of my favorite Dr. Seuss characters is the narrator featured in the book, I Had Trouble In Getting to Solla-Sollew. I frequently use this book when conducting futures and scenario planning sessions with clients in health/care. “The story opens with our happy-go-lucky narrator taking  a stroll through the Valley of Vung where nothing went wrong,” the Seussblog explains. Then one day, our hero (shown here on the right side of the picture from the book) is not paying attention to where he is walking….thus admitting, “And I learned there are troubles of more than one kind, some come from

 

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

In October 2021, the Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, would give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry. “This marks the first time in CES history that a healthcare company will take the mainstage for a keynote at the show,” CTA’s press release stated. I covered this announcement in the Health Populi blog at the time, and today want to double-down on the significance of Ford’s leading presence at #CES2022. When announced, the news was a signal that health care and the larger tech-enabled

 

The 2022 Health Populi TrendCast for Consumers and Health Citizens

I cannot recall a season when so many health consumer studies have been launched into my email inbox. While I have believed consumers’ health engagement has been The New Black for the bulk of my career span, the current Zeitgeist for health care consumerism reflects that futurist mantra: “”We tend to overestimate the effect of a technology in the short run and underestimate the effect in the long run,” coined by Roy Amara, past president of Institute for the Future. That well-used and timely observation is known as Amara’s Law. This feels especially apt right “now” as we enter 2022,

 

Fastest-Growing Brands for 2021 Are About Digital Money, Social Connections and Boomers’ Best Lives

Two pharmaceutical companies bubble up among the 20 fastest-growing brands for 2021 in Morning Consult’s report on the Fastest-Growing Brands of 2021. But the surprise in this year’s top 20 brand rankings was that five of them addressed consumers’ financial flows: Coinbase, AfterPay. Cash App, Mastercard, Chime, and Bitcoin. One year ago when I covered this study, I found  that the fastest-growing brands of 2020 had everything to do with the pandemic. They dealt with home entertainment, digital connectivity, hygiene, and indeed, health (with Pfizer and AstraZeneca the two pharma brands top-of-mind for consumers). In this year’s update, exploring consumers’

 

Support for Drug Price Negotiation Brings Partisans Together in the U.S.

Most U.S. adults across political parties favor allowing the Federal government authority to negotiate for drug prices — even after hearing the arguments against the health policy. Drug price negotiation, say by the Medicare program, is a unifying public policy in the current era of political schisms in America, based on the findings in a special Kaiser Family Foundation (KFF) Health Tracking Poll conducted in late September-early October 2021. Overall, 4 in 5 Americans favor allowing the Federal government negotiating power for prescription drug prices, shown in the first chart from the KFF report. By party, nearly all Democrats agree

 

Why CES 2022 Will Be Keynoted by a Health Care Executive

The Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, will give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry. This news is a signal that health care and the larger tech-enabled ecosystem that supports health and well-being is embedded in peoples’ everyday lives. Digital health as a category has been a growing feature at CES for over a decade, starting with the early wearable tech era of Fitbit, Nike, Omron and UnderArmour, early exhibitors at CES representing the category. By 2020, the most recent “live, in person” CES,

 

A Negative Outlook for US Hospital Margins Through 2021

In the fourth quarter of 2021, U.S. hospital margins will still be lower than before the COVID-19 pandemic, Kaufman, Hall & Associates project in their latest read on hospital finances. Kaufman Hall has been monitoring hospitals’ financial health in the coronavirus era since March 2020, month-by-month. This new report looks into the Financial Effects of COVID-19: Hospital Outlook for the Remainder of 2021. This report was conducted on behalf of the American Hospital Association (AHA), who succinctly summarized the forecast saying, “COVID-19 [is] expected to drive continued hospital losses throughout 2021.” That projection is further couched in the concern that

 

Pondering Prescription Drugs: Pricing Rx and Going Direct-to-Consumer

There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs. With the price of medicines in politicians’ and health citizens’ cross-hairs, the pharmaceutical and biotech industries have responded in many ways to the Rx pricing critiques from consumers (via, for example, Consumer Reports/Consumers Union and AARP), hospitals (through the American Hospital Association), and insurance companies (from AHIP, America’s Health Insurance Plans). The latest poll from the University of Chicago/Harris Public Policy and the Associate Press-NORC Center for Public Affairs Research quantifies the issue cross-party, finding that 74%

 

Doctors’ Offices Morph into Bill Collectors As Patients Face Growing Out-Of-Pocket Costs

In the U.S., patients have assumed the role of health care payors with growing co-payments, coinsurance amounts, and deductibles pushing peoples’ out-of-pocket costs up. This has raised the importance of price transparency, which is based on the hypothesis that if patients had access to personally-relevant price/cost information from doctors and hospitals for medical services, and pharmacies and PBMs for prescription drugs, the patient would behave as a consumer and shop around. That hypothesis has not been well proven-out: even though more health care “sellers” on the supply side have begun to post price information for services, patients still haven’t donned

 

Eli Lilly Bets on U.S. Well-Being at the Olympics

The U.S. Olympic team will be competing in Tokyo for first-place medals across many athletic events, each nation’s most physically-fit citizens going for gold. When it comes to the U.S. ranking on the world roster of population health outcomes, American ranks low on many key metrics, especially given that the U.S. does rank #1 in one key stat: healthcare spending. Reminding us of America’s lowly-placed health outcomes, the Eli Lilly Company is collaborating with Team USA, the US Olympic and Paralympic teams, to promote “Our Collective Health” with the message that, “Watching the success of our athletes will once again

 

Healthy Living Trends Inspired by COVID-19: Retailers, Food, and Consumers’ Growing Self-Care Muscles

“Self-care” took on new meaning and personal work-flows for people living in and through the coronavirus pandemic in the U.S. Acosta, the retail market research pro’s, updated our understanding consumers evolving as COVID-19 Has Elevated the Health and Wellness Trends of the Recent Years, results of a survey conducted among in May 2021. In the U.S., consumers’ take on self-care has most to do with healthy eating and nutrition (for 1 in 2 people), getting regular medical checkups (for 42%), taking exercise, relaxing, using vitamins and supplements, and getting good sleep. Healthy relationships are an integral part of self-care for

 

Dollar General, the Latest Retail Health Destination?

“What if…healthcare happened where we live, work, play, pray and shop, delivering the highest levels of retail experience?” I asked and answered in my book HealthConsuming: From Health Consumer to Health Citizen. The chapter called “The new retail health” began with that “what if,” and much of the book responded with the explanation of patients evolving toward health consumers and, ultimately, health citizens empowered and owning their health and care. This week, Dollar General announced the hiring of its first Chief Medical Officer, Dr. Albert Wu. With that announcement, America’s largest dollar-store chain makes clear its ambitions to join a

 

Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation

The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s discussion, covering: The macro- and micro-economics of Alzheimer’s and the $56,000 list price for the drug The FDA regulatory process and aftermath U.S. consumers’ bipartisan support for drug price regulation through Medicare negotiation and private/commercial sector adoption Congressional legislation addressing the price of medicines in

 

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Getting totally rid of the coronavirus isn’t likely, so we humans must accept the fact that SARS-CoV-2 will be endemic. The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape, delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. I welcomed the opportunity to learn from this team’s approach in weaving together the dynamic issues that help us to plan for the long-tail of COVID-19 and its impact on the economy and prospects for the health care industry and health citizens. The first graph illustrates the

 

What Do Democrats and Republicans Agree On? Allowing Negotiations to Lower Rx Prices

People living in the U.S. have weathered over fifteen months of life-shifts for work, school, prayer, fitness, and social lives. So you might think that the most important public priority for Congress might have something to do with COVID-19, vaccines, or health insurance coverage. But across all priorities, it turns out that prescription drug costs rank higher in Americans’ minds than any other issue in the Kaiser Family Foundation Health Tracking Poll for May 2021. Two-thirds of U.S. adults said that allowing the federal government and private insurance plans to negotiate for lower prices on Rx drugs was their top

 

Healthcare, Heal Thyself! How the Industry Can and Should Play the Trust Card

The emergence of the COVID-19 vaccine “infodemic” has slowed the ability for nations around the world to emerge out of the public health crisis. Growing cynicism among some health citizens facing the politicization of public health tactics like vaccines and facial masks is what we’re talking about. At the root is peoples’ lack of trust across a range of information providers, including government, media, business, and even peers. The 2021 Edelman Trust Barometer spotlighted the infodemic and eroding trust in the U.S. in the voices of public health, the public sector, and media. This is a global challenge as well,

 

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

You’re stressed, I’m stressed; most of us have felt stress in the COVID-19 era which began in the U.S. in the first quarter of 2020. Nearly eighteen months later, a 2021 Edelman Trust Barometer update finds that consumers’ trust in the health care industry is under stress, too — in the U.S. and around the world. The first chart from the Edelman health care update demonstrates that in most countries polled, health citizens’ trust in health care was buoyed in the first five months of 2020 (January through May): up 18 points in the U.S., 14 points in Canada and

 

Health and Getting Outside – What the 2021 Axios Harris Poll 100 Brands Mean for Health/Care

We want to go outside, drive our cars, shop for groceries, stay and get healthy. These are the key themes coming out of the 2021 Axios Harris Poll 100 on the most visible brands with high (and low) reputations among U.S. consumers. In the top-ranked “excellent” and “very good” brands numbered 1 through 50, we find five core health care brands that were most visible to U.S. consumers: Moderna ranked #3, Pfizer #7, CVS Health #24, Walgreens #46, and Kaiser Permanente #47. The only pure healthcare brand in the bottom 50 was Johnson & Johnson at #72, between Dollar General

 

Spending on Medicines In and Post-COVID Say a Lot About Patients and Larger Healthcare Trends – an IQVIA Update

Spending on medicines, globally, will rebound this year and rise above pre-pandemic levels through 2025. Between 2021 and 2025, the annual growth global growth rate for prescription drugs spending is expected to range from 3% to 6%, a $1.6 trillion bill for the worlds’s total Rx medicines market. That relatively low single-digit growth rate is tempered by savings from biosimilars and the loss of brand exclusivity (that is, more generics coming to market). On the faster-growth side, we can expect two big therapeutic areas to drive spending upward: oncology and immunology, projected to expand by 9% to 12% each year

 

The Continued Erosion of Trust in the Age of COVID

A year into the COVID-19 pandemic, most Americans are still in “survival mode,” according to an update of the 2021 Edelman Trust Barometer, Trust and the Coronavirus in the U.S. Updating the company’s annual Trust Barometer, Edelman conducted a new round of interviews in the U.S. among 2,500 people in early March. [For context, you can read my take on the 2021 Edelman Trust Barometer published during the World Economic Forum in January 2021 here in Health Populi].  The first chart shows that two in three people in the U.S. are still in a pandemic mindset, worried about safety and

 

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

2021 is the 20th anniversary of the University of Michigan Center for Value-Based Insurance Design (V-BID). On March 10th, V-BID held its annual Summit, celebrating the Center’s 20 years of innovation and scholarship. The Center is led by Dr. Mark Fendrick, and has an active and innovative advisory board. [Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics].   Some of the most important areas of the Center’s impact include initiatives addressing low-value care, waste in U.S. health care, patient assistance programs, Medicare

 

Ten Forces Shaping Health Care in 2021: A View from CVS Health

Expanding omni-channel, data-driven, cost-effective health care in the community, tailoring that care, and attending to mental health paint the picture of health through the lens of CVS Health. The company published the Health Trends Report 2021 today, calling out ten forces shaping health care this year. Those themes are, The Year of the Pharmacist The Next Step Forward in Cardiac Care Cancer Needs a Better Roadmap The EHR Hits Its Stride The Mental Health Shadow of COVID-19 Tailor Care to the Older Patient More Agents that Predict Disease Paying for the New Medical Miracle Virtual Care Goes Mainstream, and Diabetes

 

The Remarkable Rise of Pharma’s Reputation in the Pandemic

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. The study was written up by Beth Snyder Bulik in FiercePharma. Beth writes that, “a whopping two-thirds of Americans now offer a thumbs-up on pharma” as the title of her article, calling out the 30-point gain from 32% in January 2020 to 62% in February 2021. Thanks to Rob Jekielek, Managing Director of the Harris Poll, for sharing this graph with me for us to understand the details comparing pharma’s to

 

The Social Determinants of Prescription Drugs – A View From CoverMyMeds

The COVID-19 pandemic forced consumers to define what were basic or essential needs to them; for most people, those items have been hygiene products, food, and connectivity to the Internet. There’s another good that’s essential to people who are patients: prescription drugs. A new report from CoverMyMeds details the current state of medication access weaving together key health care industry and consumer data. The reality even before the coronavirus crisis emerged in early 2020 was that U.S. patients were already making painful trade-offs, some of which are illustrated in the first chart from the report. These include self-rationing prescription drug

 

Ten In Ten: Manatt’s Healthcare Priorities to 2031

The coronavirus pandemic has exposed major weaknesses in the U.S. health care system, especially laying bare inequities and inertia in American health care, explained in The Progress We Need: Ten Health Care Imperatives for the Decade Ahead from Manatt Health. The report details the ten objectives that are central to Manatt’s health care practice, a sort of team manifesto call-to-action and North Star for the next decade. Their ten must-do’s for bending the cost curve while driving constructive change for a better health care system are to: Ensure access Achieve health equity Stability the safety net and rebuild public health

 

Addressing Lives and Livelihoods with a Whole-of-Government Approach – The First Wave of Biden Health Policy

President Biden’s first few days on the job gave us a very clear view on how he sees conquering COVID: through a whole-of-government approach to public policies that bolster directly addressing the virus, along with the many forces shaping how we got here and how to come out of the pandemic era stronger. I cover this first wave of Biden health policy in my latest post for the Medecision Liberation blog titled, “Top Priorities for President Biden: COVID-19, Then Everything Else.” The plotline goes… On the day of inauguration, January 20, 2021, Joseph R. Biden was installed as the 46th

 

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

The first year of the coronavirus pandemic in America was a kind of stress test on the U.S. health care system, revealing weak links and opportunities for bad behavior. “These are not just about individual instances or bad apples,” Dr. Vikas Saini, President of The Lown Institute, explained, referring to them as “cautionary tales” of the current state of U.S. health care. Dr. Saini and his colleague Shannon Brownlee released the annual Lown Institute 2020 Shkreli Awards this week, highlighting their ten most egregious examples of the worst events in U.S. health care that happened in the past year —

 

The Fastest-Growing Brands of 2020 Are All About the Pandemic and Health

Staying home, being clean, staying entertained, eating well, and self-caring for healthcare….these are the major factors underpinning the twenty fastest-growing brands of 2020, based on Morning Consult’s annual look at the topic. Let’s look into these categories by brand, and connect the dots for health, medical care, and well-being… Connectivity as a social determinant of health. Zoom was the fastest-growing brand of the year, with 26% of U.S. consumers saying they would consider purchasing the service in November compared with 11% in January. Zoom morphed from a business meeting platform to a consumer and family-connecting service spiking on holidays like

 

Will 2021 Be the Year of Sicker Americans? Pondering Late 2020 Data from IQVIA

Yesterday, IQVIA presented their end-of-year data based on medical claims in the U.S. health care system tracking the ups, downs, and ups of the coronavirus in America. IQVIA has been tracking COVID-19 medical trends globally from early 2020. The plotline of patient encounters for vaccines, prescribed medicines, foregone procedures and diagnostic visits to doctors begs the question: in 2021, will Americans be “sicker,” discovering later-stage cancer diagnoses, higher levels of pain due to delayed hip procedures, and eroded quality of life due to leaky guts? Here are a few snapshots that paint a picture for greater morbidity and potentially more “excess

 

U.S. Health Consumers’ Growing Financial Pressures, From COVID to Cancer

Before the coronavirus pandemic, patients had been transforming into health care payors, bearing high deductibles, greater out of pocket costs, and financial risk shifting to them for medical spending. In the wake of COVID-19, we see health consumers-as-payors impacted by the pandemic, as well as for existing diagnoses and chronic care management. There is weakening in U.S. consumers’ overall household finances, the latest report from the U.S. Bureau of Economic Analysis (BEA) asserted (published 25 November 2020). In John Leer’s look into the BEA report in Morning Consult, he wrote, “Decreases in income, the expiration of unemployment benefits and increased

 

The Pandemic, Amazon, Pharmacy, and the Digital Transformation of Health Consumers

As the COVID-19 pandemic emerged in the U.S., Americans were already Primed for ecommerce — even in health care. The coronavirus accelerated the digital transformation on people as consumers — and consumers as health consumers. Today, Amazon announced the company’s launch of Amazon Pharmacy. Watch for earth-shaking (negative) impacts on the incumbent pharmacies like CVS, Rite-Aid, Walgreens, as well as discount and ecommerce players such as GoodRx. [Sidebar: as of 10 am this morning, the announcement “sunk” the retail pharmacy stocks, according to TheStreet.com]. Some context: this announcement builds on Amazon’s previous major move into pharmacy with its acquisition of

 

Will We See A Field of Dreams for the COVID-19 Vaccine in the U.S.?

“If you build it, he will come,” the voice of James Earl Jones echoes in our minds when we recall the plotline of the film, Field of Dreams. A quick summary if you don’t know the movie: the “it” was a baseball field to be built in a rural cornfield. The “he” was a baseball player, ultimately joined by a dream-team of ball players who would convene on that dreamy field to play an amazing game. Today, the day after Pfizer announced a 90% benefit for its coronavirus vaccine, bolstering Wall Street returns on 9th November 2020, two new consumer

 

Voting for Health in 2020

In the 2018 mid-term elections, U.S. voters were driven to polls with health care on their minds. The key issues for health care voters were costs (for care and prescription drugs) and access (read: protecting pre-existing conditions and expanding Medicaid). Issue #2 for 2018 voters was the economy. In 2020, as voting commences in-person tomorrow on 3rd November, U.S. voters have lives and livelihoods on their minds. It’s the pandemic – our physical lives looming largest in the polls – coupled with our fiscal and financial lives. Health is translating across all definitions for U.S. voters in November 2020: for

 

Americans Worry About Medical Bankruptcy, As Prescription Drug Costs Play Into Voters’ Concerns

One in two people in the U.S. are concerned that a major health event in their family would lead to bankruptcy, up 5 percent points over the past eighteen months. In a poll conducted with West Health, Gallup found that more younger people are concerned about medical debt risks, along with more non-white adults, published in their study report, 50% in U.S. Fear Bankruptcy Due to Major Health Event. The survey was fielded in July 2020 among 1,007 U.S. adults 18 and older. One of the basic questions in studies like these is whether a consumer could cover a $500

 

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

COVID-19 is re-shaping all industries, especially health care. And the pharma industry is challenged along with other health care sectors. In fact, the coronavirus crisis impacts on pharma are especially accelerated based on how the pandemic has affected health care providers, as seen through research from Accenture published in Reinventing Relevance: New Models for Pharma Engagement with Healthcare Providers in a COVID-19 World. For the study, Accenture surveyed 720 health care providers in general practice, oncology, immunology, and cardiology working in China, France, Japan, the United Kingdom, and the U.S., in May and June 2020. Top-line, Accenture points to four

 

Pharmacies Grow for Primary Care On-Ramps – And J.D. Power Says Consumers Like That

The use of health and wellness services delivered in retail pharmacies is growing, and health consumers’ satisfaction increases with use. That’s the headline for J.D. Power’s 2020 U.S. Pharmacy Study. This is the 12th year of J.D. Power’s U.S. Pharmacy Study, this year based on a survey of 13,378 pharmacy customers who filled a prescription between June 2019 and February 2020. The study assessed four retail prescription drug channels for consumers: brick and mortar chain drug stores, brick and mortar mass merchandisers, supermarket pharmacies, and mail order. The top ranked brands were: For brick and mortar chains, Good Neighbor Pharmacy

 

The Racial Divide Due to COVID-19 Also Applies to Healthcare and Pharma Costs

Into the sixth month of the coronavirus pandemic in the U.S., it’s clear that COVID-19 has wreaked a greater mortality and morbidity impact on people of color than on white adults. A new Gallup-West Health poll found that the coronavirus also concerns more non-white Americans than whites when it comes to the cost of health care and medicines to deal with the effects of COVID-19. Considering the cost of COVID-19 treatment, across all U.S. adults, 40% of people are concerned (extremely/concerned), and 41% are “not at all concerned.” Broken down by race, there is a stark difference in levels of

 

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Nine in ten Americans is concerned about the price of prescription drugs in the wake of the coronavirus pandemic, Gallup and West Health found in their survey on the cost of healthcare, published today. A majority of people across political party share this concern: overall, 88% of U.S. adults are concerned about rising drug prices in response to COVID19, split across party ID with: 94% of Democrats, 86% of Independents, and 84% of Republicans. By demographics, more women than men are concerned about rising costs for the three health care spending categories the survey studied: drug prices, insurance premiums, and

 

Americans’ Concerns About the US Healthcare System Loom Larger Than Worries About Their Own Care

The coronavirus pandemic has further opened the kimono of the U.S. healthcare system to Americans: four months into the COVID-19 outbreak, most consumers (62%) of people in the U.S. are more concerned about other people not having access to high quality health care versus themselves. This is a 16 point increase in concern in May 2020 compared with the response to the same question asked in February in a poll conducted by the University of Chicago Harris School of Public Policy and The Associated Press-NORC Center for Public Affairs Research (the AP-NORC Center). The AP-NORC Poll found more of this

 

Health Care In the COVID-19 Era – PwC Finds Self-Rationing of Care and Meds Especially for Chronic Care

Patients in the U.S. are self-rationing care in the era of COVID-19 by cutting spending on health care visits and prescription drugs. The coronavirus pandemic’s impact on health consumers’ spending varies depending on whether the household is generally a healthy family unit, healthy “enthusiasts,” dealing with a simple or more complex chronic conditions, or managing mental health issues. PwC explored how COVID-19 is influencing consumers’ health care behaviors in survey research conducted in early April by the Health Research Institute. The findings were published in a May 2020 report, detailing study findings among 2,533 U.S. adults polled in early April